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Abstract
Background: The pathogenesis of visceral hypersensitivity, a characteristic pathophysiological
feature of irritable bowel syndrome (IBS), remains elusive. Recent studies suggest a role for
hydrogen sulfide (H2S) in pain signaling but this has not been well studied in visceral models of
hyperalgesia. We therefore determined the role for the endogenous H2S producing enzyme
cystathionine-β-synthetase (CBS) in a validated rat model of IBS-like chronic visceral hyperalgesia
(CVH). CVH was induced by colonic injection of 0.5% acetic acid (AA) in 10-day-old rats and
experiments were performed at 8–10 weeks of age. Dorsal root ganglion (DRG) neurons
innervating the colon were labeled by injection of DiI (1,1'-dioleyl-3,3,3',3-
tetramethylindocarbocyanine methanesulfonate) into the colon wall.
Results: In rat DRG, CBS-immunoreactivity was observed in approximately 85% of predominantly
small- and medium-sized neurons. Colon specific DRG neurons revealed by retrograde labeling DiI
were all CBS-positive. CBS-positive colon neurons co-expressed TRPV1 or P2X3 receptors.
Western blotting analysis showed that CBS expression was significantly increased in colon DRGs
8 weeks after neonatal AA-treatment. Furthermore, the CBS inhibitor hydroxylamine markedly
attenuated the abdominal withdrawal reflex scores in response to colorectal distention in rats with
CVH. By contrast, the H2S donor NaHS significantly enhanced the frequency of action potentials
of colon specific DRG neurons evoked by 2 times rheobase electrical stimulation.
Conclusion: Our results suggest that upregulation of CBS expression in colonic DRG neurons and
H2S signaling may play an important role in developing CVH, thus identifying a specific
neurobiological target for the treatment of CVH in functional bowel syndromes.
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Background
Hydrogen sulfide (H2S), a gas synthesized by sulfate
reducing colonic bacteria and the endogenous enzymes
cystathionine- -synthetase (CBS) and cystathionine- -
lyase (CSE) [1-5], is increasingly recognized as a biologi-
cally important signaling molecule in various tissues and
processes including pain and inflammation [6,7]. Its puta-
tive role as a neurotransmitter is supported by recent
reports on its effects on hippocampal neurons as well as
capsaicin-sensitive peripheral sensory neurons [8-10].
With respect to the latter, there is evidence that intra-
plantar injection of NaHS (a commonly used H2S donor)
in rat hindpaws produces mechanical hyperalgesia
through activation of T-type Ca2+ channels [11], support-
ing a pro-nociceptive role for H2S. Further, H2S generation
is also enhanced in the formalin [12] and carrageenan
[13] model of persistent inflammatory pain. Systemic
injections of H2S donors in rats suppress responses to
colorectal distention (CRD) by activating KATP channels
[14,15], suggesting a possible anti-nociceptive effect. On
the other hand, colonic administration of H2S enhances
pain behaviors in response to CRD in mice [11]. However,
the role of H2S in non-inflammatory visceral hypersensi-
tivity is not known. Our aim was therefore to study the
potential role of H2S in the pathogenesis of chronic vis-
ceral hyperalgesia (CVH) in a well characterized rat model
of irritable bowel syndrome (IBS), developed in our labo-
ratory [16,17]. Our results show that CVH in this model is
associated with an upregulation of CBS expression in both
thoracolumbar (TL) and lumbarsacral (LS) DRG and that
the use of a CBS inhibitor attenuates colonic hypersensi-
tivity. H2S enhances the excitability of colon specific sen-
sory neurons in vitro and together these findings indicate
an important role for H2S signaling in IBS-like visceral
hyperalgesia. Parts of this work have been published pre-
viously in an abstract form [18].
Methods
Induction of CVH
Experiments were performed on male Sprague-Dawley
rats. Care and handling of these animals were approved
by the Institutional Animal Care and Use Committee at
the University of Texas Medical Branch and were in
accordance with the guidelines of the International Asso-
ciation for the Study of Pain. Ten day old male rat pups
received an infusion of 0.2 ml of 0.5% acetic acid (AA)
solution in saline into the colon 2 cm from the anus. Con-
trols received an equal volume of saline [16,17]. All exper-
iments were performed at age of 8–10 weeks.
Cell labeling
Colon specific DRG neurons were labeled by injection of
1,1'-dioleyl-3,3,3',3-tetramethylindocarbocyanine meth-
anesulfonate (DiI, Invitrogen) into the colon wall as
described previously [17]. In brief, when the rats were 8
weeks old, animals were anaesthetized with Ketamine (80
mg/kg, i. p.) plus Xylazine (5–10 mg/kg, i. p.). The abdo-
men was opened by midline laparotomy and the colon
was exposed. DiI, 25 mg in 0.5 ml methanol, was injected
in ~1 μl volume at 10–15 sites on the exposed colon
extending from the level of the bladder to about 6 cm in
an oral direction. To prevent leakage and possible con-
tamination of adjacent organs with the dye, the needle
was left in place for 1 minute and each injection site was
washed with normal saline following each injection. The
colon was gently swabbed prior to closing of the abdo-
men. Animals were returned to their housing and given
free access to drinking water and standard food pellets.
Immunofluorescence study
One-two weeks after DiI injection, rats were perfused tran-
scardially with 150 mL phosphate-buffered saline (PBS)
followed by 400 mL ice-cold 4% paraformaldehyde (PFA)
in PBS. DRG T13 to S2 were removed and postfixed for 1
hour in PFA and cryoprotected overnight in 20% sucrose
in PBS. Ten-micrometer sections on plus slides were incu-
bated sequentially with CBS or CSE antibody (1:200,
Abnova, CA) and then with anti-rabbit Alexa Fluor 488
(1:200, Invitrogen, CA). For triple labeling, sections were
simultaneously incubated with TRPV1 (1:200, Santa
Cruz, CA) [19] or P2X3R (1:200, Neuromics, MN) [17]
antibody and then incubated with Alexa Fluor 355. Nega-
tive control was performed by omitting the primary anti-
body. Sections were viewed with filter cubes appropriate
for DiI (rhodamine filter), Alexa 488 and 355. Images
were captured and analyzed using Metaview software
(Nikon, Melville, NY). To ensure that a neuron was
counted only once, serial sections were placed on consec-
utive slides with at least 50 μm between sections on the
same slide.
Western blotting
Protein extracts from pooled DRGs (T13-L2 and L6-S2) and
rat colon (divided into three segments: proximal, middle
and distal) were prepared in SDS buffer: 50 mM Tris-HCl,
133 mM NaCl, 2%SDS, 1 mM DTT, 1 mM PMSF, 1:100
dilution of protease inhibitor cocktail (sigma), pH = 8.
Twenty-five micrograms (25 μg) of protein were fraction-
ated on 10% polyacrylamide gels (Bio-Rad). Proteins were
transferred to PDVF membranes (Bio-Rad) at 25 V over-
night at 4°C. Membranes was blocked 2 hrs in TBS (50
mM Tris-HCl, 133 mM NaCl, pH = 7.4) and 5% dilution
of carnation nonfat milk powder. Primary antibody (anti-
CBS or CSE at 1:1000) was incubated for 2 hrs in TBS and
1% milk at room temperature. After washing in TBST
(0.5% Tween-20), membranes were incubated with HRP
conjugated secondary antibodies (1:5000, Santa Cruz,
CA) in TBS and 1% milk for 1 hr at room temperature.
Bands were visualized using ECL (Amersham) and
exposed to Kodak X-ray film. Membranes were subse-
quently stripped and re-probed for actin (1:5000, Chemi-
con, CA) or GAPDH (1:5000, Santa Cruz Biotechnology,Molecular Pain 2009, 5:44 http://www.molecularpain.com/content/5/1/44
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CA). Films were scanned and band intensities measured
using Optic Quant software (Packard instrument). CBS or
CSE data were expressed normalized to actin or GAPDH.
Behavioral testing for nocifensive responses
Visceral hypersensitivity was measured 8 weeks after neo-
natal AA treatment by grading the response of rats to
colorectal distention (CRD) as described previously
[16,17,20]. Briefly, under mild sedation 1% Brevital (25
mg/kg i.p.), a flexible balloon (5 cm) constructed from a
surgical glove finger attached to a tygon tubing was
inserted 8 cm into the descending colon and rectum via
the anus and held in place by taping the tubing to the tail.
Rats were placed in small Lucite cubicles and allowed to
adapt for 30 minutes. CRD was performed by rapidly
inflating the balloon to a constant pressure measured
using a sphygmomanometer connected to a pressure
transducer. The balloon was inflated to various pressures:
20, 40, 60 and 80 mmHg, for a 20 seconds stimulation
period followed by a 2 min rest. Behavioral responses to
CRD were measured by visual observation of the abdom-
inal withdrawal reflex (AWR) by a blinded observer and
the assignments of an AWR score were as follows: 1 = Nor-
mal behavior without response; 2 = Contraction of
abdominal muscles; 3 = Lifting of abdominal wall; 4 =
Body arching and lifting of pelvic structures.
Whole-cell patch clamp recordings
As described previously [17], DRGs (T13-L2 and L6-S2,
bilateral) were dissected out and incubated in dissecting
solution with enzymes (collagenase D, 1.5–1.8 mg/ml
and trypsin, 1.2 mg/ml; Sigma) for 1.5 hr at 34.5°C.
DRGs were then taken from the enzyme solution, washed,
and transferred to 2 ml of the dissecting solution contain-
ing DNase (0.5 mg/ml). Single cell suspension was subse-
quently obtained by repeat trituration through flame-
polished glass pipettes. Single cell activities were sampled
at 100 μs per point and filtered at 2–5 KHz. Resting and
action potentials were recorded in external solution, con-
taining (mM): NaCl 130, KCl 5, KH2PO4 2, CaCl2 2.5,
MgCl2 1, HEPES 10, glucose 10 (pH = 7.2, adjusted with
NaOH, osmolarity = 295–300 mOsm). Unless indicated,
patch-clamp pipettes had a resistance of 3–5 MΩ when
filled with the pipette solution containing (mM): potas-
sium gluconate 140, NaCl 10, HEPES 10, glucose 10,
BAPTA 5 and CaCl2 1 (pH = 7.25 adjusted with KOH;
osmolarity = 292 mOsm). Action potentials (APs) of
colon specific LS DRG neurons were evoked by two times
rheobase current stimulation (pulse width: 300 ms) under
current clamp conditions.
Application of drugs
NaHS and HA (Sigma, St Louis, MO, USA) were freshly
prepared in normal saline. For behavioral experiment,
hydroxylamine (HA, 25 μmol/kg body weight in 1 ml)
were intraperitoneally injected 30 min before measure-
ment of the number of nocifensive behavioral response to
CRD. For patch clamp experiments, NaHS (250 μM) was
applied directly to the recorded cell by pressure and there-
fore could reach equilibrium almost instantaneously. The
switching of solutions was accomplished by two compu-
ter-controlled solenoid valves. The solution change rate
could be accomplished within 10–15 ms [21].
Data analysis
Data are expressed as mean ± SEM. Statistical significance
for parametric data was analyzed by the Student's t-test for
comparison between 2 groups and by analysis of variance
followed by Tukey's test for multiple comparisons. For
AWR behavioral grades, we used a Friedman analysis of
variance (ANOVA) to determine whether scores changed
with pressure within each experimental group. Median
AWR scores at each distention pressure were compared
between treatment groups by a Mann-Whitney rank sum
test. P values less than 0.05 were considered statistically
significant.
Results
The H2S-producing enzyme CBS is expressed by colonic 
specific DRG neurons
We examined CBS expression in primary sensory neurons
by immunohistochemistry. In rat TL (Fig. 1A) and LS (Fig.
1B) DRGs, CBS was, on average, present in 85.4 ± 3.2% of
afferent neurons. CBS was predominantly expressed in
small and medium-size neurons, with large DRG neurons
staining weakly or not at all (Fig. 1C). The expression of
the other H2S producing enzyme CSE was also deter-
mined. In contrast to the finding in CBS, the CSE antibod-
CBS expression in DRG neurons Figure 1
CBS expression in DRG neurons. CBS-immunoreactivity 
(-ir) was observed in L1 (A) and S1 (B) DRG cells from con-
trol rat. Note that most of the small and medium sized cells 
were CBS-ir positive and large cells were weakly labeled or 
negative. Bar graph showed the CBS-ir in TL and LS DRG 
neurons (C). CSE-ir was not detected in L1 DRG neurons 
(D). Bar = 50 μm.Molecular Pain 2009, 5:44 http://www.molecularpain.com/content/5/1/44
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ies did not reveal reliable and reproducible staining in rat
DRG neurons and quantitative assessment was therefore
not feasible (Fig. 1D). To determine whether colon spe-
cific DRG neurons expressed the CBS, double labeling
studies were performed. Colon specific DRG neurons
were retrogradely labeled by DiI (Fig. 2A&3A) which was
injected into the colon wall 7–10 days before euthanasia.
CBS-immunoreactivity (Fig. 2B&3B) was present in all DiI
labeled colon specific DRG neurons (Fig. 2D&3D).
CBS is co-localized with TRPV1 and P2X3R in colon 
specific DRG neurons
We next examined whether CBS was co-expressed in
TRPV1- or P2X3R-positive colon specific DRG neurons
since these are two major molecules involved in transduc-
tion of nociceptive information. Triple-labeling tech-
niques were used in this experiment. Colon specific DRG
neurons were retrogradely labeled by DiI, as above. DRG
sections containing DiI labeled neurons were stained with
CBS and P2X3R or CBS and TRPV1 antibodies. All colon
specific DRG neurons that were immunoreactive for CBS
also were positive for TRPV1 (Fig. 2C, E&2F). Similarly, all
colon specific DRG neurons that were immunoreactive for
CBS also were positive for P2X3R (Fig. 3C, E&3F).
CBS expression is upregulated in the DRGs and colon in a 
rat model of CVH
We then determined the effect of neonatal colonic infu-
sion of acetic acid (AA) on CBS expression in DRG and
colon. Ten-day old pups received a single colonic infusion
of 0.2 ml of AA. Eight weeks later, the expression of CBS
in colon-related DRGs (T13-L2 and L6-S2, bilateral), as
assessed by Western blotting of protein extracts, was sig-
nificantly greater than that from control rats (Fig. 4A&4B,
p < 0.05). In addition, a significant increase of CBS expres-
sion was noted in proximal and medium colon (but not
distal colon) from rats with neonatal AA injection (Fig.
4C&4D). We also examined the expression of CSE in rat
colon. As shown in figure 4C, CSE expression in the colon
was not significantly altered 8 weeks after neonatal AA
treatment.
CBS inhibitor attenuates abdominal withdrawal reflex 
(AWR) scores in a rat model of CVH
Visceral sensitivity was determined by measuring the AWR
scores in response to colorectal distention (CRD) at 8–10
Co-expression of CBS with TRPV1 in colon specific DRG  neurons Figure 2
Co-expression of CBS with TRPV1 in colon specific 
DRG neurons. (A) Colon L1 DRG cells were labeled with 
DiI (red). (B)CBS positive cells were shown in green. (C) 
TRPV1 positive cells are shown in blue. (D) Merge of double 
labeling of DiI and CBS. (E) Merge of TRPV1-positive staining 
and DiI labeling. (F) Merge of TRPV1-positive staining and 
CBS labeling. Bar = 50 μm.
CBS TRPV1 DiI
DiI+CBS DiI+TRPV1 CBS+TRPV1
A
F E D
C B
Co-expression of CBS with P2X3R in colon specific DRG  neurons Figure 3
Co-expression of CBS with P2X3R in colon specific 
DRG neurons. (A) Colon L1 DRG cells were labeled with 
DiI (red). (B) CBS positive cells were shown in green. (C) 
P2X3R positive cells are shown in blue. (D) Merge of double 
labeling of DiI and CBS (D). (E) Merge of P2X3R-positive 
staining and DiI labeling. (F) Merge of P2X3R-positive staining 
and CBS labeling. Bar = 50 μm.
DiI CBS P2X3R
DiI+CBS CBS+P2X3R DiI+P2X3R
A
F E D
C B
Upregulation of CBS expression in DRGs and the colon Figure 4
Upregulation of CBS expression in DRGs and the 
colon. (A, B) Upregulation of CBS expression in colon 
related DRGs from neonatal AA treated rats. (C, D) CBS 
expression was increased in proximal and medium colon in 
neonatal AA-treated rats. Actin or GAPDH was used as a 
loading control for DRGs and colon, respectively. CSE 
expression was not significantly altered in colons from rats 
with neonatal AA treatment (C). n = 4 for each group. *p < 
0.05 compared with controls.
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weeks of age. In accordance with our previously reported
results [16,17], the AWR scores were significantly higher
in neonatal AA-treated rats at 20, 40, 60 and 80 mmHg
distention pressures than those in saline treated rats (Fig.
5A, *P < 0.05). We then examined the change in response
to CRD after administration of the CBS inhibitor, hydrox-
ylamine (HA), 30 minutes before balloon distention. We
used a relatively high concentration of this agent (25
μmol/kg in 1 ml), a dose similar to those selected by other
investigators [22]. In sensitized rats, HA treatment caused
a significant decline in the mean AWR scores to CRD at
20, 40, 60 and 80 mmHg when compared with pre-injec-
tion (Fig. 5B). In control rats, HA had no significant effects
on the AWR scores (Fig. 5C), suggesting that this agent did
not act as a non-specific analgesic and that CBS do not
normally participate in the responses to CRD.
The H2S donor NaHS increases excitability of colon 
specific DRG neurons
Since our previous experiments demonstrated that neona-
tal AA treatment increased colon specific DRG neuronal
excitability [23], we determined whether H2S mimicked
the effects induced by neonatal AA treatment. Perfusion of
freshly prepared H2S donor NaHS (250 μM) for 2 mins in
LS DRG (L6-S2, bilateral) neurons from control rats (n =
7) did not alter the resting membrane potential (RP) in
the majority of recorded cells (22/33, 66.7%). Only 6 cells
showed a slight depolarization and 5 cells displayed a
slight hyperpolarization (data not shown). This is in con-
sistent with our previous findings that neonatal AA treat-
ment did not alter RPs of colon specific LS DRG neurons
[23]. However, perfusion of NaHS led to a significant
increase in numbers of action potentials (APs) in 68.2%
of the neurons (n = 15) evoked by two times rheobase cur-
rent stimulation (Fig. 6B&6D). The remaining 7 cells did
not show any changes in numbers of APs evoked by two
times rheobase current stimulation. The average of num-
bers of APs for all 15 neurons after NaHS application were
6.8 ± 0.7, which is significantly higher than those before
NaHS application (PRE 1.5 ± 0.2, n = 15, *p < 0.05). This
effect lasted about 10 minutes after wash (Fig. 6C), indi-
cating that H2S has a long term effect on excitability of
colon specific DRG neurons. These data demonstrated
that H2S donor NaHS enhanced excitability of colon spe-
cific DRG neurons.
Discussion
Our study shows that the H2S producing enzyme cystath-
ionine β-synthase (CBS) is expressed by a subpopulation
of primary sensory neurons (Figs. 1, 2 &3) and is upregu-
lated in a rat model of IBS-like chronic visceral hyperalge-
sia (Fig. 4). CBS upregulation may contribute to chronic
visceral hyperalgesia since a CBS inhibitor significantly
attenuates the AWR scores in neonatal AA-treated rats
(Fig. 5). In addition, H2S donor NaHS greatly enhanced
the frequency of action potentials of DRG neurons in vitro
(Fig. 6). These data strongly suggest that CBS-H2S signal-
ing may play an important role in "functional" visceral
pain i.e. pain occurring in the absence of overt structural
or inflammatory processes.
There is considerable support for a role of H2S as a neuro-
modulator [24-26] or an endogenous gaseous transmitter
Effect of CBS inhibitor on AWR (abdominal withdrawal  reflex) in response to colorectal distention (CRD) Figure 5
Effect of CBS inhibitor on AWR (abdominal with-
drawal reflex) in response to colorectal distention 
(CRD). (A) Neonatal AA-treatment significantly enhanced 
the AWR scores. *p < 0.05 compared with controls. (B) CBS 
inhibitor hydroxylamine (HA, 25 μmol/Kg body weight) sig-
nificantly attenuated the AWR scores in neonatal AA-treated 
rats. *p < 0.05 compared with Pre-HA. (C) HA did not pro-
duce any effect on AWR scores in healthy control rats.
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[27]. In physiological conditions, H2S has been found to
regulate key neuronal functions, including induction of
long-term potentiation and modulation of NMDA recep-
tor currents in the hippocampus [24,28]. H2S has been
reported to produce inward or outward currents on dorsal
raphe serotonergic neurons in vitro [29]. H2S can also reg-
ulate the release of corticotrophin-releasing hormone
from the hypothalamus [30]. H2S is an important endog-
enous vasoactive factor and is an identified gaseous
opener of KATP channels in vascular smooth muscle cells
[27].
Endogenous H2S is also an important mediator of inflam-
mation in a variety of models [6,31]. Along with this,
there is growing evidence of its involvement in nocicep-
tion in both somatic [32,33] and visceral [11,14,15]
organs. However, this role is likely to be complex as sug-
gested by the somewhat conflicting reports in the litera-
ture. Distrutti and colleagues have shown that systemic
administration of H2S donors attenuates the response to
CRD in both healthy and post-colitic rats; this effect is
sensitive to glibenclamide, suggesting that it is mediated
by KATPchannels [14,15]. On the other hand, intracolonic
H2S donor NaHS enhanced spontaneous visceral pain
behavior as well as referred hyperalgesia and spinal ERK
expression in mice, an effect that appears to be mediated
by T-type calcium channels as it is blocked by mibefradil
but not by verapamil (an L-type channel blocker) or glib-
enclamide [11]. The reasons for these discrepant findings
may include but not limit to H2S concentration, effect of
inflammation on H2S action and H2S action sites. The
concentration of H2S may not be an explanation for the
different results since the same dose of H2S used by two
different groups produced the different effects [11,14,15].
Tissue inflammation may have an influence on H2S
actions. In this animal model, however, no histological
signs of inflammation/injuries or significant changes in
MPO activities were observed in the colons 8 weeks after
neonatal AA treatment as reported previously [16]. Thus,
the different effects of H2S in AA-treated rats were not due
to inflammation/injury. The site of action or/and the
source of H2S may be most likely related to the different
effect of H2S as has been suggested in somatic pain mod-
els [33]. Thus, systemic administration of exogenous H2S
may activate central antinociceptive mechanisms whereas
peripheral H2S administration or endogenous sources
may invoke pro-nociceptive effects. Further experiments
on the mechanism of H2S signaling pathway are war-
ranted.
CBS and systathionine γ-lyase (CSE) are two important
enzymes for generation of endogenous H2S [1-5]. These
two enzymes have been found in many types of mamma-
lian cells in the central nervous system as well as periph-
eral tissues [10,25,27,34,35]. Both enzymes have also
been shown to be expressed by rat colonic tissue [15]. CSE
and CBS have also been localized to colonic enteric neu-
rons and CSE, but not CBS, to interstitial cells of Cajal in
guinea pig colon [10]. We have confirmed previous stud-
ies on the expression of CBS and CSE in the colon and fur-
ther have shown that CBS, but not CSE, is expressed by
colon-specific sensory neurons (Fig. 1), where it is local-
ized to nociceptive neurons, indicating that CBS is a major
enzyme responsible for the endogenous production of
H2S in these cells. We have also shown that CBS expres-
sion in both sensory neurons and the colon is dynamic
and is upregulated in a model of chronic non-inflamma-
tory visceral hypersensitivity. Theoretically, enhanced H2S
production from either a colonic or a neuronal source can
affect the function of sensory neurons in our model and
contribute to both enhanced pain as well as the secreto-
motor response that has previously been shown in guinea
pigs [10]. An additional source of H2S comes from sulfate-
reducing bacteria in the GI tract [36-38]. Further research
will indicate the relative importance of these various
Alteration in action potential (AP) frequency Figure 6
Alteration in action potential (AP) frequency. Repre-
sentative traces of APs were induced by 300-ms depolarizing 
current pulses injected through the patch pipette at two 
times rheobase in DiI labeled neurons from control rats 
under current-clamp conditions. (A) AP recorded before 
(PRE) application of H2S donor NaHS. (B) APs recorded after 
2 mins perfusion of H2S donor NaHS (250 μM). Application 
of NaHS significantly increased the APs frequency evoked by 
two times rheobase electrical stimulation. (C) APs recorded 
after 10 min wash. (D) Bar graph showing a significant 
increase in average number of APs elicited by a two times 
rheobase current injection after application of NaHS (*P < 
0.01 compared with PRE).
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sources in health and disease. Our studies showed that
CBS inhibitor attenuated the AWR scores in neonatal AA-
treated rats (Fig. 5B) and no significant effect was seen in
control rats (Fig. 5C), suggesting that this was not a non-
specific analgesic effect. This also suggests that the role of
CBS in signaling colonic distension may not be as impor-
tant in health as in the sensitized state. Taken together,
our results suggest but do not prove that CBS may be an
important source of endogenous H2S and a credible ther-
apeutic target for visceral pain syndromes.
Although the detailed mechanisms by which H2S induces
visceral hyperalgesia have yet to be fully investigated, our
data and that of others suggest that colonic nociceptors
are a prime site of action. H2S has been shown to enhance
the excitability of enteric neurons, possibly via TRPV1
receptors on extrinsic afferent terminals [10]. Others have
shown that stimulation with H2S enhances T-type calcium
currents in small sensory neurons in vitro [11]. In this
study, we provide new evidence for the first time to show
that H2S donor NaHS increased the number of action
potentials evoked by electrical stimulation in colon spe-
cific DRG neurons (Fig. 6), indicating that H2S may
increase the neuronal excitability. This effect may result
from the previously reported activation of T-type calcium
channels and/or involve potassium and/or sodium ion
channels. In addition, we showed that CBS-ir was present
abundantly in small and medium-size neurons of DRGs
and they co-localized with TRPV1 and P2X3 receptors,
suggesting a possible interaction between these mole-
cules. Both of these receptors are upregulated in our
model of IBS-like pain [16,17] and further studies are
needed to investigate whether and how H2S modulates
their function and/or expression.
In conclusion, although there is a discrepancy of H2S
effects in the literature, our data demonstrate that CBS-
H2S signaling pathways may play a role in chronic visceral
hyperalgesia, even in the absence of overt inflammation
of the colon wall. Our results also identify CBS as a poten-
tial target for novel agents for the treatment of visceral
pain in IBS and related disorders.
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